Last reviewed · How we verify
Hyperbaric bupivacaine spinal
Hyperbaric bupivacaine spinal is a Small molecule drug developed by B.P. Koirala Institute of Health Sciences. It is currently FDA-approved.
At a glance
| Generic name | Hyperbaric bupivacaine spinal |
|---|---|
| Sponsor | B.P. Koirala Institute of Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries (NA)
- Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery (NA)
- Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery (PHASE2)
- The Effect of Epidural Anesthesia on Optic Nerve Sheath Diameter Measurements in Total Knee Prosthesis Surgery (NA)
- Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty (NA)
- Comparison of Post-Dural Puncture Headache After Spinal Anesthesia Using Median Versus Paramedian Approach (NA)
- Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery
- Comparison of Hypotension After Spinal Anesthesia With Hyperbaric Vs Isobaric Bupivacaine in Elective Cesarean After Colloid Preloading. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyperbaric bupivacaine spinal CI brief — competitive landscape report
- Hyperbaric bupivacaine spinal updates RSS · CI watch RSS
- B.P. Koirala Institute of Health Sciences portfolio CI
Frequently asked questions about Hyperbaric bupivacaine spinal
What is Hyperbaric bupivacaine spinal?
Hyperbaric bupivacaine spinal is a Small molecule drug developed by B.P. Koirala Institute of Health Sciences.
Who makes Hyperbaric bupivacaine spinal?
Hyperbaric bupivacaine spinal is developed and marketed by B.P. Koirala Institute of Health Sciences (see full B.P. Koirala Institute of Health Sciences pipeline at /company/b-p-koirala-institute-of-health-sciences).
What development phase is Hyperbaric bupivacaine spinal in?
Hyperbaric bupivacaine spinal is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing